North Central London Cancer Conference
19 November 2024, Emirates Stadium
09:30-16:30

In smaller groups we will explore issues which are highly relevant to the NCL cancer system. The input of a diverse group of stakeholders will help inform the work of the Cancer Alliance in the short to medium-term. These sessions will each run twice. On the registration form you will be asked to pick two sessions you would like to attend.

1. Surveil and Prevail: How can surveillance support the NHS to identify more cancers at an earlier stage?  

In this interactive session, we will explore the potential opportunities and challenges of designing surveillance pathways, including understanding the impact on patients and identifying emerging innovations and technologies.

2. AI and Cancer: Hype versus Reality – Our capacity and capability to adopt AI in a timely and ethical way

While there is a lot of hype about AI, it has often failed to translate in a practical way within healthcare. In this session, we will explore some of the ethical considerations around AI. What skills do we need to make confident decisions around its adoption? Are our governance and approval mechanisms fit-for-purpose? Can one common approach across NCL ever be achieved?

3. Partners in Care – Building confidence and collaboration: How we support people living with and beyond cancer to have a leading role in optimising their own health and wellbeing

In this session, we will explore how people living with and beyond cancer can be supported to self-manage elements of their own care and shape the support they receive to live actively and well. We will identify barriers and solutions for people with cancer accessing support and generate ideas for measuring the impact of information signposting, referral and advice. 

4. Turning the tide on cancer prevention: How can we ensure prevention is no longer the Cinderella of cancer programming?

Prevention is everyone’s business. How can we raise its profile and shift the balance of investment in cancer towards prevention? What will it take for government to prioritise longer-term health outcomes when we are missing our short-term cancer targets? And among all the stakeholders engaged in prevention, what is the role of the Cancer Alliance?

5. Unlocking better outcomes with data: how can we improve patient outcomes through better sharing of data and information?

In this session, colleagues from a system and provider perspective will lead discussions on the benefits of sharing data and information across organisations and how we might best enable this.